New data show durable progression-free survival among exceptional responders to PARP inhibitors after discontinuation, though selection bias limits causal interpretation.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/parp-discontinuation-maintains-outcomes-ovarian-cancer-2026a1000mb3?src=rss
Author :
Publish date : 2026-07-01 08:34:00
Copyright for syndicated content belongs to the linked Source.
